Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial Journal Club General.
Joseph Finkelstein, MD, PhD Chronic Disease Informatics Program Johns Hopkins University.
Institutional Review Board (IRB) Human Subject Research Office (HSRO) University of Miami and Affiliated Institutions.
Investigational New Drug (IND) Orientation Responsibilities of IND Sponsor-Investigators MICHR IND/IDE Assistance Program (MIAP)
Barbara E. Bierer, M.D. Senior Vice President, Research, BWH Director, Center for Faculty Development & Diversity BWH Surgery Resident Research Conference.
1 Community-Based Participatory Research María Luisa Zúñiga, PhD Associate Professor Division of Global Public Health, Medicine Division of Child Development.
HeartCare II: CHF Patricia Flatley Brennan, RN, Ph.D., FAAN Laura J. Burke, R.N., Ph.D., FAAN Pascale Carayon, Ph.D. Ben Tzion Karsh, Ph.D. Margaret Sebern,
Common Audit Findings UTHSC Institutional Review Board (IRB)
Form Builder: Hopkins-wide Data Collection Tool for Research Projects
Everyday Preparedness for the Challenges of FDA-Regulated Research
Institutional Review Board (IRB) Human Subject Research Office (HSRO) University of Miami
1 Burns Beach near Brighton, Western Australia RPS has won a series of awards from the Urban Development Institute of Australia - including the Water Sensitive.
